Metabolomics-based Approach to Pharmacotherapy Personalization: Advantages and Limitations

Author(s): Dmitry L. Maslov*, Elena E. Balashova, Oxana P. Trifonova, Petr G. Lokhov

Journal Name: Current Pharmacogenomics and Personalized Medicine
Formerly Current Pharmacogenomics

Volume 16 , Issue 3 , 2018

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: A patient-focused approach to treatment, where individual characteristics provide the selection of optimal medication strategy for a particular patient, is the trend of current clinical therapy. An application of advanced “omics” technologies, which enable to detect the inter-individual variability in genomic, transcriptomic, proteomic, and metabolomic levels is a perspective way to achieve such personalization.

Objective: In this review, the advantages of metabolomics-based approach as one of the most promising and perspective for individualization of pharmacotherapy are demonstrated. This approach provides a prediction of the inter-individual variability in drug response and allows monitoring effectiveness of drug treatment, correcting it in account of individual parameters of patients.

Method: Comparative analysis of metabolomics-based approach and the current methods of drug treatment personalization are carried out.

Results: Advantages and limitations of the metabolomics-based approach were identified and discussed.

Conclusion: The perspective ways for solution of limitations of the metabolomics-based approach are considered.

Keywords: Metabolomics, pharmacometabolomics, pharmacogenomics, personalized medicine, mass spectrometry, metabolomics-based approach.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 24 January, 2019
Page: [192 - 198]
Pages: 7
DOI: 10.2174/1875692116666181008144905

Article Metrics

PDF: 47
PRC: 1